Nektar Therapeutics | NKTR - EPS Earnings Per Share


Nektar Therapeutics reported $-1.78 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
Agios Pharmaceuticals USD -1.69 0 Jun/2026
ALKERMES USD 0 0.4 Jun/2026
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Amgen USD 6.29 1.14 Jun/2026
Baxter International USD 0.56 0.2 Jun/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Cara Therapeutics USD -0.72 0.14 Mar/2026
Cipla INR 9.76 2.9 Jun/2026
Dr.Reddys Laboratories INR 5.33 0.47 Jun/2026
Eisai JPY 64.71 76.24 Jun/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Exelixis USD 0.91 0.04 Jun/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
GlaxoSmithKline GBP 0.51 0.08 Jun/2026
Grifols EUR 0.16 0.02 Mar/2026
Halozyme Therapeutics USD 2.28 0.68 Jun/2026
Incyte USD 3.09 1.28 Jun/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Ironwood Pharmaceuticals USD 0.31 0.07 Jun/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Merck USD -0.13 1.15 Jun/2026
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Novartis USD 2.41 0.42 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sarepta Therapeutics USD 0.64 2.52 Jun/2026
Takeda JPY 71.65 87.21 Jun/2026
Teva Pharmaceutical Industries USD 0.06 1.51 Jun/2026
Xencor USD -0.29 1.42 Jun/2026